Liesbeth Weynants leads the team at HOYNG ROKH MONEGIER, which leverages the strength of the firm's offices in Paris and Amsterdam to support clients on the full spectrum of IP issues concerning the life sciences sector. Weynants is highly regarded for her expertise in advising on a broad range of regulatory issues, including reimbursement and pharmacovigilance matters, as well as assisting with patent enforcement actions and the development of portfolio strategies. Dividing his time between Brussels and Paris, firm managing partner Benoît Strowel is well versed in handling patent litigation across Europe. Ine Letten brings experience in handling issues concerning unfair business practices and multi-jurisdictional patent litigation. Tim Robrechts assists with a broad range of IP-related issues. Charlotte Behets Wydemans left the firm in February 2024.
Testimonials
Collated independently by Legal 500 research team.
‘The life sciences industry sector knowledge of Hoygn Rokh Monegier across their European offices is superb.’
‘The healthcare and life sciences practice combines a strong experience in both patent litigation and complex Belgian regulatory issues.’
Key clients
- Biogen
- Johnson & Johnson